Roche N, Boudarham J, Hardy A, Bonnyaud C, Bensmail B
Service of lof Physiology and Functional Exploration, University of Versailles Saint Quentin en Yvelines, Hôpital Raymond Poincaré, Garches, France -
Eur J Phys Rehabil Med. 2015 Aug;51(4):361-70. Epub 2014 Sep 12.
Botulinum toxin type A (BTX-A) injection in the rectus femoris (RF) is commonly used to treat decreased peak knee flexion in swing phase of the gait in hemiplegic patients. However, the effect of BTX-A varies between 5° to 10° depending on the studies. Peak knee flexion also increases during fast gait and could constitute a way to predict the effect of BTX-A injection in the RF.
To determine if changes in gait parameters during fast gait before injection could predict the effect of RF BTX-A injection on peak knee flexion in hemiplegic patients.
Prospective observational study.
A neurological rehabilitation department in a university hospital
Twenty two hemiplegic patients with stiff knee gait mainly due to spasticity of the RF and treated by RF-BTX-A-injection.
Patients' gait was analyzed using a 3D motion analysis system and force plates. The gait recordings were performed before (PRE-RF-BTX-A:spontaneous and fast gait speed) and one month after RF-BTX-A-injection (POST-RF-BTX-A:spontaneous gait speed). Correlations between the percentage change in gait parameters during fast gait before RF-BTX-A-injection and the percentage increase in peak knee flexion POST-RF-BTX-A injection at spontaneous speed were analyzed.
The percentage improvement in peak knee flexion in the fast gait condition before injection was the only parameter correlated with the percentage increase in peak knee flexion POST-RF-BTX-A injection. This was confirmed by a stepwise linear regression. The percentage increase in peak knee flexion POST-RF-BTX-A injection was also correlated with the percentage increase in knee flexion angular velocity at toe-off in the fast gait condition.
The percentage increase in peak knee flexion in swing during fast gait before injection is a useful predictor of the increase in peak knee flexion following RF BTX-A injection in chronic stroke patients with RF spasticity.
In stroke patients with SKG which is mainly caused by spasticity of the RF muscle, evaluating changes which occur during fast gait might help the therapist to identify patients who would benefit the most from BTX-A injection in the RF muscle.
A型肉毒毒素(BTX-A)注射至股直肌(RF)常用于治疗偏瘫患者步态摆动期膝关节屈曲峰值降低的情况。然而,根据研究不同,BTX-A的效果在5°至10°之间有所差异。快速步态期间膝关节屈曲峰值也会增加,这可能是预测RF注射BTX-A效果的一种方法。
确定注射前快速步态期间步态参数的变化是否可预测RF注射BTX-A对偏瘫患者膝关节屈曲峰值的影响。
前瞻性观察研究。
一家大学医院的神经康复科
22例主要因RF痉挛导致膝关节僵硬步态的偏瘫患者,接受RF-BTX-A注射治疗。
使用三维运动分析系统和测力板对患者步态进行分析。在RF-BTX-A注射前(PRE-RF-BTX-A:自然步态和快速步态速度)以及注射后1个月(POST-RF-BTX-A:自然步态速度)进行步态记录。分析RF-BTX-A注射前快速步态期间步态参数的百分比变化与注射后自然速度下膝关节屈曲峰值百分比增加之间的相关性。
注射前快速步态条件下膝关节屈曲峰值的改善百分比是与注射后RF-BTX-A膝关节屈曲峰值增加百分比相关的唯一参数。逐步线性回归证实了这一点。注射后RF-BTX-A膝关节屈曲峰值的增加百分比也与快速步态条件下足趾离地时膝关节屈曲角速度的增加百分比相关。
注射前快速步态摆动期膝关节屈曲峰值的增加百分比是RF痉挛的慢性卒中患者注射RF BTX-A后膝关节屈曲峰值增加的有用预测指标。
在主要由RF肌肉痉挛引起的SKG中风患者中,评估快速步态期间发生的变化可能有助于治疗师识别出从RF肌肉注射BTX-A中获益最大的患者。